Research Partnership makes annual donation to Forever Angels baby home
Research Partnership has made a seasonal donation of US$5,000 to its chosen charity, Forever Angels. Fundraising efforts by its employees throughout the year contributed to this total.
We are committed to supporting the baby home in their mission of caring for and improving the lives of orphaned and abandoned infants in Tanzania.
Syndicated patient record data
Track the global market in real time
Do you need a closer connection to your marketplace? Watch our new animated video and discover how our Therapy Watch Heroes can help you achieve a competitive edge through gaining an in-depth understanding of drug therapies, market shares over time, switching patterns and patient demographics.
Pharma Market Research Report - Predictions for 2016
PMR invited US President Harriet Kozak to submit her predictions for 2016
2016 will continue to see an increase in the number of requests for research projects investigating the market opportunity for rare disease and orphan drugs. Last year the FDA approved 48 drugs in rare diseases, including both novel and repurposed drugs. Rare diseases are attractive to pharma for a number of reasons. Firstly, manufacturers of orphan drugs are awarded longer market exclusivity, reduced regulatory fees, tax incentives and line extensions. Secondly, although patient populations for each disease in every market are small, if the drug gains approval across a number of indications, the manufacturer can increase its potential revenue. Thirdly, if successful, manufacturers have the opportunity to be a market leader in a niche area. However, commercialization of orphan drugs can be challenging, because of the size of patient populations, the cost of drugs, and the difficulty in diagnosing conditions. A successful product launch requires a marketing strategy based on a focused product portfolio with a clear demonstration of the drug’s clinical value and patient benefit. Manufacturers must engage and effectively work with patient advocacy groups, funding agencies and all relevant stakeholders. All of these factors require insightful market intelligence to leverage the opportunity. Market research agencies will need to…
Pharmaceutical Market Research Conference 2016
We were delighted to exhibit and present a paper at the Pharmaceutical Market Research Conference this February in Parsippany, NJ.
Representing Research Partnership at the event were US President Harriet Kozak and Director Phil Rosenberg.
Harriet presented the paper ‘Fighting Talk: The effect of using military style language when talking about cancer’. In this presentation, delegates heard first-hand accounts from cancer survivors, a leading oncologist and a pharma market research professional about how they feel about the use of language and communication in oncology. The paper also explored the challenges that manufacturers face with regard to communicating effectively, and determines how market research can support their efforts in ensuring brand messaging speaks directly, and appropriately, to the target audience.
Nicole Bender Moreira promoted to Associate Director, Singapore office
Research Partnership is delighted to announce the promotion of Nicole Bender Moreira to Associate Director in recognition of the contribution she has made to the growing success of our Singapore office.
Research Partnership is delighted to announce the promotion of Nicole Bender Moreira to Associate Director in recognition of the contribution she has made to the growing success of our Singapore office. Nicole has over 7 years of healthcare market research experience and is a key member of the specialist Emerging Markets team.
Over the past year Nicole has worked on a number of large scale quantitative publication research and patient journey studies with both regional and global teams. As well as contributing to the planning and organisation of Research Partnership’s Singapore Client Meeting in October, Nicole also lead the presentations at the event by sharing her expertise on mobile research in Asia. Outside of her project work, Nicole has also been instrumental in driving recruitment in our Singapore office by leading events at various universities throughout the year.